retatrutide safety profile (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 Retatrutide Triple Hormone Receptor Agonist:

This article examines the science, potential risks, and NHS guidance surrounding this off-label approach

Two protocols dominate the research community

Patients using GLP-1 RAs for weight loss (AOM) were more likely to discontinue due to perceived completion of therapy or no longer needing the medication suggesting that some view these drugs as short-term solutions rather than components of ongoing chronic disease management

GLP-1 stands for glucagon like peptide1, a naturally occurring hormone that helps regulate appetite, digestion, and blood sugar

Instead of activating one receptor, it activates three: GLP-1, GIP, and glucagon

Can I have my medical records with Felix shared with my primary care provider